{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:37:24Z","timestamp":1787020644986,"version":"build-2736575974"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,26]],"date-time":"2019-12-26T00:00:00Z","timestamp":1577318400000},"content-version":"vor","delay-in-days":25,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1K23 HL140092"],"award-info":[{"award-number":["1K23 HL140092"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01HL128278"],"award-info":[{"award-number":["1R01HL128278"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01 HL141917"],"award-info":[{"award-number":["1R01 HL141917"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Ultrasound"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Echocardiography (echo) is widely used to guide therapeutic decision-making for patients being considered for MitraClip. Relative utility of two- (2D) and three-dimensional (3D) echo predictors of MitraClip response, and impact of MitraClip on mitral annular geometry, are uncertain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The study population comprised patients with advanced (&gt; moderate) MR undergoing MitraClip. Mitral annular geometry was quantified on pre-procedural 2D transthoracic echocardiography (TTE) and intra-procedural 3D transesophageal echocardiography (TEE); 3D TEE was used to measure MitraClip induced changes in annular geometry. Optimal MitraClip response was defined as \u2264mild MR on follow-up (mean 2.7\u2009\u00b1\u20092.5\u2009months) post-procedure TTE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Eighty patients with advanced MR underwent MitraClip; 41% had optimal response (\u2264mild MR). Responders had smaller pre-procedural global left ventricular (LV) end-diastolic size and mitral annular diameter on 2D TTE (both\n                      <jats:italic>p<\/jats:italic>\n                      \u2009\u2264\u20090.01), paralleling smaller annular area and circumference on 3D TEE (both\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001). Mitral annular size yielded good diagnostic performance for optimal MitraClip response (AUC 0.72,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01). In multivariate analysis, sub-optimal MitraClip response was independently associated with larger pre-procedural mitral annular area on 3D TEE (OR 1.93 per cm\n                      <jats:sup>2<\/jats:sup>\n                      \/m\n                      <jats:sup>2<\/jats:sup>\n                      [CI 1.19\u20133.13],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.007) and global LV end-diastolic volume on 2D TTE (OR 1.29 per 10\u2009ml\/m\n                      <jats:sup>2<\/jats:sup>\n                      [CI 1.02\u20131.63],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.03). Substitution of 2D TTE derived mitral annular diameter for 3D TEE data demonstrated a lesser association between pre-procedural annular size (OR 5.36 per cm\/m\n                      <jats:sup>2<\/jats:sup>\n                      [CI 0.95\u201330.19],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.06) and sub-optimal MitraClip response. Matched pre- and post-procedural TEE analyses demonstrated MitraClip to acutely decrease mitral annular area and circumference (all\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) as well as mitral tenting height, area, and volume (all\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05): Magnitude of MitraClip induced reductions in mitral annular circumference on intra-procedural 3D TEE was greater among patients with, compared to those without, sub-optimal MitraClip response (&gt;mild MR) on followup TTE (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.017); greater magnitude of device-induced annular reduction remained associated with sub-optimal MitraClip response even when normalized for pre-procedure annular circumference (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.028).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>MitraClip alters mitral annular geometry as quantified by intra-procedural 3D TEE. Pre-procedural mitral annular dilation and magnitude of device-induced reduction in mitral annular size on 3D TEE are each associated with sub-optimal therapeutic response to MitraClip.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12947-019-0181-z","type":"journal-article","created":{"date-parts":[[2019,12,26]],"date-time":"2019-12-26T11:02:24Z","timestamp":1577358144000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Transcatheter MitraClip repair alters mitral annular geometry \u2013 device induced annular remodeling on three-dimensional echocardiography predicts therapeutic response"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8420-8604","authenticated-orcid":false,"given":"Jiwon","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Chiara","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar K.","family":"Khalique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa Q.","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razia","family":"Sultana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukund","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Jantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasfumi","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B.","family":"Devereux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shing Chiu","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey W.","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark B.","family":"Ratcliffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan W.","family":"Weinsaft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,26]]},"reference":[{"key":"181_CR1","unstructured":"Abbott receives FDA approval for expanded indication for MitraClip\u2122 device. 2019. https:\/\/abbott.mediaroom.com\/2019-03-14-Abbott-Receives-FDA-Approval-for-Expanded-Indication-for-MitraClip-TM-Device."},{"issue":"4","key":"181_CR2","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.jacc.2013.04.030","volume":"62","author":"L Mauri","year":"2013","unstructured":"Mauri L, Foster E, Glower DD, Apruzzese P, Massaro JM, Herrmann HC, Hermiller J, Gray W, Wang A, Pedersen WR, et al. 4-year results of a randomized controlled trial of percutaneous repair versus surgery for mitral regurgitation. J Am Coll Cardiol. 2013;62(4):317\u201328.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"181_CR3","doi-asserted-by":"publisher","first-page":"e000056","DOI":"10.1136\/openhrt-2014-000056","volume":"1","author":"S Toggweiler","year":"2014","unstructured":"Toggweiler S, Zuber M, Surder D, Biaggi P, Gstrein C, Moccetti T, Pasotti E, Gaemperli O, Faletra F, Petrova-Slater I, et al. Two-year outcomes after percutaneous mitral valve repair with the MitraClip system: durability of the procedure and predictors of outcome. Open Heart. 2014;1(1):e000056.","journal-title":"Open Heart"},{"issue":"1","key":"181_CR4","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jtcvs.2015.09.099","volume":"151","author":"N Buzzatti","year":"2016","unstructured":"Buzzatti N, De Bonis M, Denti P, Barili F, Schiavi D, Di Giannuario G, La Canna G, Alfieri O. What is a \u201cgood\u201d result after transcatheter mitral repair? Impact of 2+ residual mitral regurgitation. J Thorac Cardiovasc Surg. 2016;151(1):88\u201396.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"6","key":"181_CR5","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1002\/ccd.28147","volume":"93","author":"J Kim","year":"2019","unstructured":"Kim J, Alakbarli J, Palumbo MC, Xie LX, Rong LQ, Tehrani NH, Brouwer LR, Devereux RB, Wong SC, Bergman GW, et al. Left ventricular geometry predicts optimal response to percutaneous mitral repair via MitraClip: integrated assessment by two- and three-dimensional echocardiography. Catheter Cardiovasc Interv. 2019;93(6):1152\u201360.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"24","key":"181_CR6","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1056\/NEJMoa1805374","volume":"379","author":"JF Obadia","year":"2018","unstructured":"Obadia JF, Messika-Zeitoun D, Leurent G, Iung B, Bonnet G, Piriou N, Lefevre T, Piot C, Rouleau F, Carrie D, et al. Percutaneous repair or medical treatment for secondary mitral regurgitation. N Engl J Med. 2018;379(24):2297\u2013306.","journal-title":"N Engl J Med"},{"key":"181_CR7","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMoa1806640","volume":"379","author":"GW Stone","year":"2018","unstructured":"Stone GW, Lindenfeld J, Abraham WT, Kar S, Lim S, Mishell JM, Whisenant B, Grayburn PA, Rinaldi M, Kapadia SR, et al. Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med. 2018;379:2307.","journal-title":"N Engl J Med"},{"key":"181_CR8","doi-asserted-by":"publisher","first-page":"e0223472","DOI":"10.1371\/journal.pone.0223472","volume":"14","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Wang VY, Morgan AE, Kim J, Handschumacher MD, Moskowitz CS, Levine RA, Liang G, Guccione JM, Weinsaft JW, et al. Mechanical effects of Mitraclip on leaflet stress and myocardial strain in functional mitral regurgitation \u2013 A finite element modeling study. PLOS:One. 2019;14:e0223472.","journal-title":"PLOS:One"},{"issue":"5","key":"181_CR9","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1016\/S0735-1097(99)00396-4","volume":"34","author":"V Palmieri","year":"1999","unstructured":"Palmieri V, Dahlof B, DeQuattro V, Sharpe N, Bella JN, de Simone G, Paranicas M, Fishman D, Devereux RB. Reliability of echocardiographic assessment of left ventricular structure and function: the PRESERVE study. Prospective randomized study evaluating regression of ventricular enlargement. J Am Coll Cardiol. 1999;34(5):1625\u201332.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"181_CR10","doi-asserted-by":"publisher","first-page":"e005115","DOI":"10.1161\/CIRCIMAGING.116.005115","volume":"9","author":"J Kim","year":"2016","unstructured":"Kim J, Di Franco A, Seoane T, Srinivasan A, Kampaktsis PN, Geevarghese A, Goldburg SR, Khan SA, Szulc M, Ratcliffe MB, et al. Right ventricular dysfunction impairs effort tolerance independent of left ventricular function among patients undergoing exercise stress myocardial perfusion imaging. Circ Cardiovasc Imaging. 2016;9(11):e005115.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"6","key":"181_CR11","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/0002-9149(86)90771-X","volume":"57","author":"RB Devereux","year":"1986","unstructured":"Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57(6):450\u20138.","journal-title":"Am J Cardiol"},{"issue":"11","key":"181_CR12","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1111\/echo.13668","volume":"34","author":"J Kim","year":"2017","unstructured":"Kim J, Rodriguez-Diego S, Srinivasan A, Brown RM, Pollie MP, Di Franco A, Goldburg SR, Siden JY, Ratcliffe MB, Levine RA, et al. Echocardiography-quantified myocardial strain-a marker of global and regional infarct size that stratifies likelihood of left ventricular thrombus. Echocardiography. 2017;34(11):1623\u201332.","journal-title":"Echocardiography"},{"issue":"3","key":"181_CR13","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.amjcard.2014.05.008","volume":"114","author":"SC Volo","year":"2014","unstructured":"Volo SC, Kim J, Gurevich S, Petashnick M, Kampaktsis P, Feher A, Szulc M, Wong FJ, Devereux RB, Okin PM, et al. Effect of myocardial perfusion pattern on frequency and severity of mitral regurgitation in patients with known or suspected coronary artery disease. Am J Cardiol. 2014;114(3):355\u201361.","journal-title":"Am J Cardiol"},{"issue":"3","key":"181_CR14","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S0002-9149(00)01362-X","volume":"87","author":"EC Jones","year":"2001","unstructured":"Jones EC, Devereux RB, Roman MJ, Liu JE, Fishman D, Lee ET, Welty TK, Fabsitz RR, Howard BV. Prevalence and correlates of mitral regurgitation in a population-based sample (the strong heart study). Am J Cardiol. 2001;87(3):298\u2013304.","journal-title":"Am J Cardiol"},{"issue":"4","key":"181_CR15","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.echo.2017.01.007","volume":"30","author":"WA Zoghbi","year":"2017","unstructured":"Zoghbi WA, Adams D, Bonow RO, Enriquez-Sarano M, Foster E, Grayburn PA, Hahn RT, Han Y, Hung J, Lang RM, et al. Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr. 2017;30(4):303\u201371.","journal-title":"J Am Soc Echocardiogr"},{"issue":"12","key":"181_CR16","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.echo.2011.09.015","volume":"24","author":"S Gelsomino","year":"2011","unstructured":"Gelsomino S, van Garsse L, Luca F, Lorusso R, Cheriex E, Rao CM, Caciolli S, Vizzardi E, Crudeli E, Stefano P, et al. Impact of preoperative anterior leaflet tethering on the recurrence of ischemic mitral regurgitation and the lack of left ventricular reverse remodeling after restrictive annuloplasty. J Am Soc Echocardiogr. 2011;24(12):1365\u201375.","journal-title":"J Am Soc Echocardiogr"},{"issue":"10","key":"181_CR17","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.jacc.2015.12.054","volume":"67","author":"P Sorajja","year":"2016","unstructured":"Sorajja P, Mack M, Vemulapalli S, Holmes DR Jr, Stebbins A, Kar S, Lim DS, Thourani V, McCarthy P, Kapadia S, et al. Initial experience with commercial transcatheter mitral valve repair in the United States. J Am Coll Cardiol. 2016;67(10):1129\u201340.","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"181_CR18","first-page":"30800","volume":"S0894-7317","author":"D Oguz","year":"2019","unstructured":"Oguz D, Eleid MF, Dhesi S, Pislaru SV, Mankad SV, Malouf JF, Nkomo VT, Oh JK, Holmes DR, Reeder GS, et al. Quantitative three-dimensional echocardiographic correlates of optimal mitral regurgitation reduction during transcatheter mitral valve repair. J Am Soc Echocardiogr. 2019;S0894-7317(19):30800\u20134.","journal-title":"J Am Soc Echocardiogr"},{"issue":"12","key":"181_CR19","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.jacc.2013.02.094","volume":"62","author":"F Maisano","year":"2013","unstructured":"Maisano F, Franzen O, Baldus S, Schafer U, Hausleiter J, Butter C, Ussia GP, Sievert H, Richardt G, Widder JD, et al. Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. J Am Coll Cardiol. 2013;62(12):1052\u201361.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"181_CR20","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jcin.2013.12.198","volume":"7","author":"E Lubos","year":"2014","unstructured":"Lubos E, Schluter M, Vettorazzi E, Goldmann B, Lubs D, Schirmer J, Treede H, Reichenspurner H, Blankenberg S, Baldus S, et al. MitraClip therapy in surgical high-risk patients: identification of echocardiographic variables affecting acute procedural outcome. JACC Cardiovasc Interv. 2014;7(4):394\u2013402.","journal-title":"JACC Cardiovasc Interv"},{"issue":"4","key":"181_CR21","doi-asserted-by":"publisher","first-page":"e280","DOI":"10.1093\/ejcts\/ezt321","volume":"44","author":"H Reichenspurner","year":"2013","unstructured":"Reichenspurner H, Schillinger W, Baldus S, Hausleiter J, Butter C, Schaefer U, Pedrazzini G, Maisano F. Clinical outcomes through 12 months in patients with degenerative mitral regurgitation treated with the MitraClip(R) device in the ACCESS-EUrope phase I trial. Eur J Cardiothorac Surg. 2013;44(4):e280\u20138.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"9","key":"181_CR22","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.jacc.2014.06.1166","volume":"64","author":"G Nickenig","year":"2014","unstructured":"Nickenig G, Estevez-Loureiro R, Franzen O, Tamburino C, Vanderheyden M, Luscher TF, Moat N, Price S, Dall'Ara G, Winter R, et al. Percutaneous mitral valve edge-to-edge repair: in-hospital results and 1-year follow-up of 628 patients of the 2011-2012 pilot European sentinel registry. J Am Coll Cardiol. 2014;64(9):875\u201384.","journal-title":"J Am Coll Cardiol"}],"container-title":["Cardiovascular Ultrasound"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12947-019-0181-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12947-019-0181-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12947-019-0181-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,24]],"date-time":"2020-12-24T19:14:35Z","timestamp":1608837275000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiovascularultrasound.biomedcentral.com\/articles\/10.1186\/s12947-019-0181-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["181"],"URL":"https:\/\/doi.org\/10.1186\/s12947-019-0181-z","relation":{},"ISSN":["1476-7120"],"issn-type":[{"value":"1476-7120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"7 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This protocol was approved by the Weill Cornell Institutional Review Board, which approved analysis of pre-existing data for research purposes. Informed consent for use of research data was waived, as this was a retrospective study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable (patient identifiers not included in manuscript).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Ratcliffe previously performed a computational modeling study of the Ventouch device (for ventricular reshaping in functional mitral regurgitation) under contract to Mardil Medical Inc.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31"}}